Practical guidelines for managing adults with 22q11.2 deletion syndrome

Genetics in Medicine

Volumn 17, Issue 8, 2015, Pages 599-609

  Fung, Wai Lun Alan ^a,b,c,d   Butcher, Nancy J ^b,e   Costain, Gregory ^b,e   Andrade, Danielle M ^a,e   Boot, Erik ^a,b,c,d,f   Chow, Eva W C ^b,d   Chung, Brian ^g   Cytrynbaum, Cheryl ^h   Faghfoury, Hanna ⁱ   Fishman, Leona ^h   García Miñaúr, Sixto ^j   George, Susan ^a,b,e   Lang, Anthony E ^e,k   Repetto, Gabriela ^l   Shugar, Andrea ^h   Silversides, Candice ^a,i,m   Swillen, Ann ^n,o   Van Amelsvoort, Therese ^p   Mcdonald Mcginn, Donna M ^q,r   Bassett, Anne S ^a,b,c,d,e,i  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f ACADEMIC MEDICAL CENTER   (Netherlands)

^g UNIVERSITY OF HONG KONG   (Hong Kong)

^h HOSPITAL FOR SICK CHILDREN   (Canada)

ⁱ UNIVERSITY HEALTH NETWORK   (Canada)

^j HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^k TORONTO WESTERN HOSPITAL   (Canada)

^l UNIVERSIDAD DEL DESARROLLO   (Chile)

^m MOUNT SINAI HOSPITAL   (Canada)

ⁿ UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^o UNIVERSITY OF LEUVEN   (Belgium)

^p MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^q CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^r UNIVERSITY OF PENNSYLVANIA   (United States)

more..

Author keywords

22q11.2 deletion; clinical practice guidelines; DiGeorge syndrome; treatment; velocardiofacial syndrome

Indexed keywords

ADULT; ANXIETY DISORDER; ATTENTION DEFICIT DISORDER; AUTISM; BEHAVIOR DISORDER; BIPOLAR DISORDER; CHROMOSOME DELETION 22Q11; COGNITIVE DEFECT; CONGENITAL HEART DISEASE; DEGENERATIVE DISEASE; ECHOCARDIOGRAPHY; GENETIC COUNSELING; GENETIC SCREENING; HUMAN; HYPOCALCEMIA; HYPOMAGNESEMIA; HYPOTHYROIDISM; IMMUNE DEFICIENCY; INTELLECTUAL IMPAIRMENT; INTELLIGENCE QUOTIENT; LEARNING DISORDER; MAJOR DEPRESSION; MORBIDITY; OBESITY; PARKINSON DISEASE; PHENOTYPE; PRACTICE GUIDELINE; PREMATURE MORTALITY; REVIEW; SCHIZOPHRENIA; SEIZURE; SEXUAL HEALTH; SOCIAL PSYCHOLOGY; SUBSTANCE ABUSE; SYSTEMATIC REVIEW; CHROMOSOME 22; CHROMOSOME DELETION; DIGEORGE SYNDROME; FEMALE; GENETICS; MALE;

ADULT; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 22; DIGEORGE SYNDROME; FEMALE; GENETIC TESTING; HUMANS; MALE; PRACTICE GUIDELINES AS TOPIC;

EID: 84931360375     PISSN: 10983600     EISSN: 15300366     Source Type: Journal    
DOI: 10.1038/gim.2014.175     Document Type: Review

References (74)

1. Bassett AS, McDonald-McGinn DM, Devriendt K, et al.; International 22q11.2 Deletion Syndrome Consortium. Practical guidelines for managing patients with 22q11.2 deletion syndrome. J Pediatr 2011; 159: 332-339.e1
2. McDonald-McGinn DM, Sullivan KE. Chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Medicine (Baltimore) 2011; 90: 1-18
3. Costain G, McDonald-McGinn DM, Bassett AS. Prenatal genetic testing with chromosomal microarray analysis identifies major risk variants for schizophrenia and other later-onset disorders. Am J Psychiatry 2013; 170: 1498
4. Kaminsky EB, Kaul V, Paschall J, et al. An evidence-based approach to establish the functional and clinical significance of copy number variants in intellectual and developmental disabilities. Genet Med 2011; 13: 777-784
5. Cooper GM, Coe BP, Girirajan S, et al. A copy number variation morbidity map of developmental delay. Nat Genet 2011; 43: 838-846
6. McDonald-McGinn DM, Tonnesen MK, Laufer-Cahana A, et al. Phenotype of the 22q11.2 deletion in individuals identified through an affected relative: cast a wide FISHing net! Genet Med 2001; 3: 23-29
7. Vogels A, Schevenels S, Cayenberghs R, et al. Presenting symptoms in adults with the 22q11 deletion syndrome. Eur J Med Genet 2014; 57: 157-162
8. Murphy KC, Jones LA, Owen MJ. High rates of schizophrenia in adults with velocardio-facial syndrome. Arch Gen Psychiatry 1999; 56: 940-945
9. Bassett AS, Chow EW, Husted J, et al. Clinical features of 78 adults with 22q11 seletion syndrome. Am J Med Genet A 2005; 138: 307-313
10. Fung WLA, McEvilly R, Fong J, Silversides C, Chow E, Bassett A. Elevated prevalence of generalized anxiety disorder in adults with 22q11.2 deletion syndrome. Am J Psychiatry 2010; 167: 998
11. Philip N, Bassett A. Cognitive, behavioural and psychiatric phenotype in 22q11.2 deletion syndrome. Behav Genet 2011; 41: 403-412
12. Evers LJ, van Amelsvoort TA, Candel MJ, Boer H, Engelen JJ, Curfs LM. Psychopathology in adults with 22q11 deletion syndrome and moderate and severe intellectual disability. J Intellect Disabil Res 2014; 58: 915-925
13. Schneider M, Debbané M, Bassett AS, et al.; International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome. Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome. Am J Psychiatry 2014; 171: 627-639
14. Hercher L, Bruenner G. Living with a child at risk for psychotic illness: the experience of parents coping with 22q11 deletion syndrome: an exploratory study. Am J Med Genet A 2008; 146A: 2355-2360
15. Karas DJ, Costain G, Chow EW, Bassett AS. Perceived burden and neuropsychiatric morbidities in adults with 22q11.2 deletion syndrome. J Intellect Disabil Res 2014; 58: 198-210
16. Butcher NJ, Chow EW, Costain G, Karas D, Ho A, Bassett AS. Functional outcomes of adults with 22q11.2 deletion syndrome. Genet Med 2012; 14: 836-843
17. Ferrell RB, Wolinsky EJ, Kauffman CI, Flashman LA, McAllister TW. Neuropsychiatric syndromes in adults with intellectual disability: issues in assessment and treatment. Curr Psychiatry Rep 2004; 6: 380-390
18. Tang SX, Yi JJ, Calkins ME, et al. Psychiatric disorders in 22q11.2 deletion syndrome are prevalent but undertreated. Psychol Med 2014; 44: 1267-1277
19. Bassett AS, Chow EW. Schizophrenia and 22q11.2 deletion syndrome. Curr Psychiatry Rep 2008; 10: 148-157
20. Bassett AS, Scherer SW, Brzustowicz LM. Copy number variations in schizophrenia: critical review and new perspectives on concepts of genetics and disease. Am J Psychiatry 2010; 167: 899-914
21. van Amelsvoort T, Henry J, Morris R, et al. Cognitive deficits associated with schizophrenia in velo-cardio-facial syndrome. Schizophr Res 2004; 70: 223-232
22. Bassett AS, Chow EW, AbdelMalik P, Gheorghiu M, Husted J, Weksberg R. The schizophrenia phenotype in 22q11 deletion syndrome. Am J Psychiatry 2003; 160: 1580-1586
23. Chow EW, Watson M, Young DA, Bassett AS. Neurocognitive profile in 22q11 deletion syndrome and schizophrenia. Schizophr Res 2006; 87: 270-278
24. Stoddard J, Niendam T, Hendren R, Carter C, Simon TJ. Attenuated positive symptoms of psychosis in adolescents with chromosome 22q11.2 deletion syndrome. Schizophr Res 2010; 118: 118-121
25. Yuen T, Chow EW, Silversides CK, Bassett AS. Premorbid adjustment and schizophrenia in individuals with 22q11.2 deletion syndrome. Schizophr Res 2013; 151: 221-225
26. Butcher N, Fung WLA, Fitzpatrick L, et al. Response to clozapine in a clinically identifiable subtype of schizophrenia: 22q11.2 deletions mediate side effect risk and dosage. Br J Psychiatry, in press
27. Bassett AS, Chow EWC, Hodgkinson KA. Genetics of schizophrenia and psychotic disorders. In: Smoller JW, Sheidley BR, Tsuang MT (eds). Psychiatric Genetics: Applications in Clinical Practice. American Psychiatric Publishing: Washington, DC, 2008: 99-130
28. Antshel KM, Shprintzen R, Fremont W, Higgins AM, Faraone SV, Kates WR. Cognitive and psychiatric predictors to psychosis in velocardiofacial syndrome: a 3-year follow-up study. J Am Acad Child Adolesc Psychiatry 2010; 49: 333-344
29. Gothelf D, Schaer M, Eliez S. Genes, brain development and psychiatric phenotypes in velo-cardio-facial syndrome. Dev Disabil Res Rev 2008; 14: 59-68
30. Vorstman JA, Breetvelt E, Duijff SN, et al. A decline in verbal intelligence precedes the onset of psychosis in patients with the 22q11.2 deletion syndrome. JAMA Psychiatry, in press
31. Martin N, Mikhaelian M, Cytrynbaum C, et al. 22q11.2 deletion syndrome: attitudes towards disclosing the risk of psychiatric illness. J Genet Couns 2012; 21: 825-834
32. Bassett AS, Marshall CR, Lionel AC, Chow EW, Scherer SW. Copy number variations and risk for schizophrenia in 22q11.2 deletion syndrome. Hum Mol Genet 2008; 17: 4045-4053
33. Vorstman JA, Breetvelt EJ, Thode KI, Chow EW, Bassett AS. Expression of autism spectrum and schizophrenia in patients with a 22q11.2 deletion. Schizophr Res 2013; 143: 55-59
34. Swillen A, Vandeputte L, Cracco J, et al. Neuropsychological, learning and psychosocial profile of primary school aged children with the velo-cardio-facial syndrome (22q11 deletion): evidence for a nonverbal learning disability? Child Neuropsychol 1999; 5: 230-241
35. Swillen A, Vogels A, Devriendt K, Fryns JP. Chromosome 22q11 deletion syndrome: update and review of the clinical features, cognitive-behavioral spectrum, and psychiatric complications. Am J Med Genet 2000; 97: 128-135
36. De Smedt B, Swillen A, Verschaffel L, Ghesquière P. Mathematical learning disabilities in children with 22q11.2 deletion syndrome: a review. Dev Disabil Res Rev 2009; 15: 4-10
37. Henry JC, van Amelsvoort T, Morris RG, Owen MJ, Murphy DG, Murphy KC. An investigation of the neuropsychological profile in adults with velo-cardio-facial syndrome (VCFS). Neuropsychologia 2002; 40: 471-478
38. Kao A, Mariani J, McDonald-McGinn DM, et al. Increased prevalence of unprovoked seizures in patients with a 22q11.2 deletion. Am J Med Genet A 2004; 129A: 29-34
39. Andrade DM, Krings T, Chow EW, Kiehl TR, Bassett AS. Hippocampal malrotation is associated with chromosome 22q11.2 microdeletion. Can J Neurol Sci 2013; 40: 652-656
40. Ryan AK, Goodship JA, Wilson DI, et al. Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J Med Genet 1997; 34: 798-804
41. Cheung EN, George SR, Andrade DM, Chow EW, Silversides CK, Bassett AS. Neonatal hypocalcemia, neonatal seizures, and intellectual disability in 22q11.2 deletion syndrome. Genet Med 2014; 16: 40-44
42. González W, Bautista RE. Seizures and EEG findings in an adult patient with DiGeorge syndrome: a case report and review of the literature. Seizure 2009; 18: 648-651
43. Choi JH, Shin YL, Kim GH, et al. Endocrine manifestations of chromosome 22q11.2 microdeletion syndrome. Horm Res 2005; 63: 294-299
44. Cuneo BF, Driscoll DA, Gidding SS, Langman CB. Evolution of latent hypoparathyroidism in familial 22q11 deletion syndrome. Am J Med Genet 1997; 69: 50-55
45. Kar PS, Ogoe B, Poole R, Meeking D. Di-George syndrome presenting with hypocalcaemia in adulthood: two case reports and a review. J Clin Pathol 2005; 58: 655-657
46. Cheung EN, George SR, Costain GA, et al. Prevalence of hypocalcaemia and its associated features in 22q112 deletion syndrome. Clin Endocrinol (Oxf) 2014; 81: 190-196
47. Brauner R, Le Harivel de Gonneville A, Kindermans C, et al. Parathyroid function and growth in 22q11.2 deletion syndrome. J Pediatr 2003; 142: 504-508
48. Kawame H, Adachi M, Tachibana K, et al. Graves disease in patients with 22q11.2 deletion. J Pediatr 2001; 139: 892-895
49. Guzman ML, Delgado I, Lay-Son G, Willans E, Puga A, Repetto GM. Growth in Chilean infants with chromosome 22q11 microdeletion syndrome. Am J Med Genet A 2012; 158A: 2682-2686
50. Gennery AR. Immunological aspects of 22q11.2 deletion syndrome. Cell Mol Life Sci 2012; 69: 17-27
51. Sullivan KE, Jawad AF, Randall P, et al. Lack of correlation between impaired T cell production, immunodeficiency, and other phenotypic features in chromosome 22q11.2 deletion syndromes. Clin Immunol Immunopathol 1998; 86: 141-146
52. Matsuoka R, Kimura M, Scambler PJ, et al. Molecular and clinical study of 183 patients with conotruncal anomaly face syndrome. Hum Genet 1998; 103: 70-80
53. Bretelle F, Beyer L, Pellissier MC, et al. Prenatal and postnatal diagnosis of 22q11.2 deletion syndrome. Eur J Med Genet 2010; 53: 367-370
54. John AS, McDonald-McGinn DM, Zackai EH, Goldmuntz E. Aortic root dilation in patients with 22q11.2 deletion syndrome. Am J Med Genet A 2009; 149A: 939-942
55. Warnes CA, Williams RG, Bashore TM, et al.; American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease); American Society of Echocardiography; Heart Rhythm Society; International Society for Adult Congenital Heart Disease; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2008; 52: e143-e263
56. Silversides CK, Kiess M, Beauchesne L, et al. Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: outflow tract obstruction, coarctation of the aorta, tetralogy of Fallot, Ebstein anomaly and Marfans syndrome. Can J Cardiol 2010; 26: e80-e97
57. Gatzoulis MA, Walters J, McLaughlin PR, Merchant N, Webb GD, Liu P. Late arrhythmia in adults with the mustard procedure for transposition of great arteries: a surrogate marker for right ventricular dysfunction? Heart 2000; 84: 409-415
58. Ghai A, Silversides C, Harris L, Webb GD, Siu SC, Therrien J. Left ventricular dysfunction is a risk factor for sudden cardiac death in adults late after repair of tetralogy of Fallot. J Am Coll Cardiol 2002; 40: 1675-1680
59. Hickey EJ, Veldtman G, Bradley TJ, et al. Late risk of outcomes for adults with repaired tetralogy of Fallot from an inception cohort spanning four decades. Eur J Cardiothorac Surg 2009; 35: 156-164; discussion 164
60. Costain G, Chow EW, Silversides CK, Bassett AS. Sex differences in reproductive fitness contribute to preferential maternal transmission of 22q11.2 deletions. J Med Genet 2011; 48: 819-824
61. Tarquinio DC, Jones MC, Jones KL, Bird LM. Growth charts for 22q11 deletion syndrome. Am J Med Genet A 2012; 158A: 2672-2681
62. Besseau-Ayasse J, Violle-Poirsier C, Bazin A, et al. A French collaborative survey of 272 fetuses with 22q11.2 deletion: ultrasound findings, fetal autopsies and pregnancy outcomes. Prenat Diagn 2014; 34: 424-430
63. Hatton R, Colman JM, Sermer M, Grewal J, Silversides CK. Cardiac risks and management of complications in pregnant women with congenital heart disease. Future Cardiol 2012; 8: 315-327
64. Costain G, Chow EW, Ray PN, Bassett AS. Caregiver and adult patient perspectives on the importance of a diagnosis of 22q11.2 deletion syndrome. J Intellect Disabil Res 2012; 56: 641-651
65. Krahn LE, Maraganore DM, Michels VV. Childhood-onset schizophrenia associated with parkinsonism in a patient with a microdeletion of chromosome 22. Mayo Clin Proc 1998; 73: 956-959
66. Booij J, van Amelsvoort T, Boot E. Co-occurrence of early-onset Parkinson disease and 22q11.2 deletion syndrome: potential role for dopamine transporter imaging. Am J Med Genet A 2010; 152A: 2937-2938
67. Butcher N, Kiehl T, Hazrati L, et al. Individuals with 22q11.2 deletion syndrome are at increased risk of early-onset Parkinson disease: identification of a novel genetic form of Parkinson disease and its clinical implications. JAMA Neurol 2013: 1359-1366
68. Bassett AS, Chow EW, Husted J, et al. Premature death in adults with 22q11.2 deletion syndrome. J Med Genet 2009; 46: 324-330
69. Gerdes M, Solot C, Wang PP, McDonald-McGinn DM, Zackai EH. Taking advantage of early diagnosis: preschool children with the 22q11.2 deletion. Genet Med 2001; 3: 40-44
70. McDonald-McGinn DM, Zackai EH. Genetic counseling for the 22q11.2 deletion. Dev Disabil Res Rev 2008; 14: 69-74
71. Vantrappen G, Devriendt K, Swillen A, et al. Presenting symptoms and clinical features in 130 patients with the velo-cardio-facial syndrome. The Leuven experience. Genet Couns 1999; 10: 3-9
72. Digilio MC, Angioni A, De Santis M, et al. Spectrum of clinical variability in familial deletion 22q11.2: from full manifestation to extremely mild clinical anomalies. Clin Genet 2003; 63: 308-313
73. Devriendt K, Swillen A, Fryns JP, Proesmans W, Gewillig M. Renal and urological tract malformations caused by a 22q11 deletion. J Med Genet 1996; 33: 349
74. Finucane B. Genetic counseling for women with intellectual disabilities. In: LeRoy BS, Veach PM, Bartels DM (eds). Genetic Counseling Practice: Advanced Concepts and Skills. Wiley-Blackwell: Hoboken, NJ, 2010: 281-303